InvestorsHub Logo
Followers 7
Posts 1303
Boards Moderated 0
Alias Born 03/08/2019

Re: None

Tuesday, 05/31/2022 11:25:57 AM

Tuesday, May 31, 2022 11:25:57 AM

Post# of 3433
Auxly Cannabis has 135 per cent upside, says Raymond James

“While as expected seasonally soft 1Q22 sales did impact XLY, the company maintained its #1 national position in Cannabis 2.0 sales, moved into the #4 position by total adult-use sales, and drove strong sales in its relatively newflower category,” Sarugaser said. “We expect sales will rebound in 2Q22 and escalate materially through 3Q and 4Q22, driven by a growing national market, XLY’s continued capture of market share, and XLY now having put some 1Q22 supply chain and flower availability headwinds in the rearview, for the most part.”

https://www.cantechletter.com/2022/05/auxly-cannabis-has-135-per-cent-upside-says-raymond-james/#

To me a .40 price target seems resonable considering they're the leader of Cannabis 2.0 and hold a 20% national market share in exploding vape sales. Now that Auxly has two Imperial connected board members the fat is getting cut and better business strategies are being adopted. Like acquiring 100% of Sunens which should drive down concentrate and flower costs now and in the future. Glad to see cannabis sales are increaasing in the current quarter for the next report. Fingers Crossed :) glta

Canadian cannabis sales rebound strongly in March to record CA$358.8M

https://mjbizdaily.com/canadian-cannabis-sales-rebound-strongly-in-march-to-record-ca358-8-million/

Posts are my opinion only, and not advice of any kind. glta